tirzepatide 3ml Weight Loss Injections Tirzepatide 60mg/3mL (20mg/mL) | Pipeline
Description
Tirzepatide is a dual GIP and GLP-1 receptor agonist used for the treatment of type 2 diabetes mellitus
Oxid Med Cell Longev
House of Representatives, 15 Jan
Get insights on navigating GLP-1 antagonist shortages and compounds as we navigate demand and supply challenges.
The Lancet 2026
It is classified as a triple receptor agonist and is identified by CAS number 2381089-83-2. Purity is verified at 99% via RP-HPLC prior to dispatch
